Source:http://linkedlifedata.com/resource/pubmed/id/11113570
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2-3
|
pubmed:dateCreated |
2001-1-16
|
pubmed:abstractText |
The brain distribution of the enantiomers of the antimalarial drug mefloquine is stereoselective according to the species. This stereoselectivity may be related to species-specific differences in the properties of some membrane-bound transport proteins, such as P-glycoprotein (P-gp). The interactions of racemic mefloquine and its individual enantiomers with the P-glycoprotein efflux transport system have been analysed in immortalised rat brain capillary endothelial GPNT cells. Parallel studies were carried out for comparison in human colon carcinoma Caco-2 cells. The cellular accumulation of the P-glycoprotein substrate, [(3)H]vinblastine, was significantly increased both in GPNT cells and in Caco-2 cells when treated with racemic mefloquine and the individual enantiomers. In GPNT cells, the (+)-stereoisomer of mefloquine was up to 8-fold more effective than its antipode in increasing cellular accumulation of [(3)H]vinblastine, while in Caco-2 cells, both enantiomers were equally effective. These results suggest that racemic mefloquine and its enantiomers are effective inhibitors of P-gp. Furthermore, a stereoselective P-glycoprotein inhibition is observed in rat cells but not in human cells. The efflux of [(14)C]mefloquine from GPNT cells was decreased when the cells were incubated with the P-gp modulators, verapamil, cyclosporin A or chlorpromazine, suggesting that MQ could be a P-gp substrate.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0006-3002
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
1524
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
212-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11113570-Animals,
pubmed-meshheading:11113570-Antimalarials,
pubmed-meshheading:11113570-Brain Chemistry,
pubmed-meshheading:11113570-Caco-2 Cells,
pubmed-meshheading:11113570-Cell Line,
pubmed-meshheading:11113570-Cerebrovascular Circulation,
pubmed-meshheading:11113570-Cyclosporine,
pubmed-meshheading:11113570-Endothelium, Vascular,
pubmed-meshheading:11113570-Gene Expression Regulation,
pubmed-meshheading:11113570-Humans,
pubmed-meshheading:11113570-Mefloquine,
pubmed-meshheading:11113570-P-Glycoprotein,
pubmed-meshheading:11113570-Rats,
pubmed-meshheading:11113570-Stereoisomerism,
pubmed-meshheading:11113570-Substrate Specificity
|
pubmed:year |
2000
|
pubmed:articleTitle |
Interactions of racemic mefloquine and its enantiomers with P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT.
|
pubmed:affiliation |
Pharmacie Clinique, Université Paris, Châtenay-Malabry, France. ytpham@netcourrier.com
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|